InsideArbitrage Potential Deal Alert: Rain Oncology (RAIN) approached by Concentra for $1.25 per share
According to an amended 13D filing, Rain Oncology (RAIN) received an acquisition proposal from Concentra Biosciences, an affiliate of Tang Capital Partners, for $1.25 per
Read More